Case Report of Metronidazole-Induced Encephalopathy
This report describes the case of an 83-year-old woman who was admitted to a hospitalist service with weakness and falls. She was transferred from an outside facility where she was treated with 3 courses of metronidazole for diagnosed Clostridium difficile colitis and presumed reoccurrences. Magneti...
Gespeichert in:
Veröffentlicht in: | Wisconsin medical journal (Madison, Wis.) Wis.), 2017-12, Vol.116 (5), p.221 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | 221 |
container_title | Wisconsin medical journal (Madison, Wis.) |
container_volume | 116 |
creator | Clements, Adam |
description | This report describes the case of an 83-year-old woman who was admitted to a hospitalist service with weakness and falls. She was transferred from an outside facility where she was treated with 3 courses of metronidazole for diagnosed Clostridium difficile colitis and presumed reoccurrences. Magnetic resonance imaging (MRI) demonstrated T2 enhancement of the dorsal pons and dentate nuclei consistent with metronidazole-induced encephalopathy. Her metronidazole was stopped and her symptoms resolved. This condition is rare, poorly understood, and causes reversible changes in the brain that are detectable through T2-weighted MRI. It will need ongoing study with current widespread use of metronidazole. |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_29357212</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29357212</sourcerecordid><originalsourceid>FETCH-LOGICAL-p93t-d6bbd0b0eda0eb173589d732786abdf8af949ce3b28f3f59e66d4892c5e226753</originalsourceid><addsrcrecordid>eNo1zsFKAzEQgOEcFFurryD7AoEk0ySToyxVCxVBei_JzoRWtpuwuz3Up_egnv7bx38jlloFlBqdXoj7afpSCoxFvBMLE8B6o81SQBsnbj65lnFuSm7eeR7LcKL4XXqW24EuHVOzGTqux9iXGufj9UHc5thP_PjXldi_bPbtm9x9vG7b552sAWZJLiVSSTFFxUl7sBjIg_HoYqKMMYd16BiSwQzZBnaO1hhMZ9kY5y2sxNMvWy_pzHSo4-kcx-vhfx5-AGAbP7M</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Case Report of Metronidazole-Induced Encephalopathy</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Clements, Adam</creator><creatorcontrib>Clements, Adam</creatorcontrib><description>This report describes the case of an 83-year-old woman who was admitted to a hospitalist service with weakness and falls. She was transferred from an outside facility where she was treated with 3 courses of metronidazole for diagnosed Clostridium difficile colitis and presumed reoccurrences. Magnetic resonance imaging (MRI) demonstrated T2 enhancement of the dorsal pons and dentate nuclei consistent with metronidazole-induced encephalopathy. Her metronidazole was stopped and her symptoms resolved. This condition is rare, poorly understood, and causes reversible changes in the brain that are detectable through T2-weighted MRI. It will need ongoing study with current widespread use of metronidazole.</description><identifier>ISSN: 1098-1861</identifier><identifier>PMID: 29357212</identifier><language>eng</language><publisher>United States</publisher><subject>Aged, 80 and over ; Anti-Infective Agents - adverse effects ; Brain Diseases - chemically induced ; Brain Diseases - diagnostic imaging ; Clostridium Infections - drug therapy ; Colitis - drug therapy ; Female ; Humans ; Magnetic Resonance Imaging ; Metronidazole - adverse effects</subject><ispartof>Wisconsin medical journal (Madison, Wis.), 2017-12, Vol.116 (5), p.221</ispartof><rights>Copyright© Wisconsin Medical Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29357212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clements, Adam</creatorcontrib><title>Case Report of Metronidazole-Induced Encephalopathy</title><title>Wisconsin medical journal (Madison, Wis.)</title><addtitle>WMJ</addtitle><description>This report describes the case of an 83-year-old woman who was admitted to a hospitalist service with weakness and falls. She was transferred from an outside facility where she was treated with 3 courses of metronidazole for diagnosed Clostridium difficile colitis and presumed reoccurrences. Magnetic resonance imaging (MRI) demonstrated T2 enhancement of the dorsal pons and dentate nuclei consistent with metronidazole-induced encephalopathy. Her metronidazole was stopped and her symptoms resolved. This condition is rare, poorly understood, and causes reversible changes in the brain that are detectable through T2-weighted MRI. It will need ongoing study with current widespread use of metronidazole.</description><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - adverse effects</subject><subject>Brain Diseases - chemically induced</subject><subject>Brain Diseases - diagnostic imaging</subject><subject>Clostridium Infections - drug therapy</subject><subject>Colitis - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Metronidazole - adverse effects</subject><issn>1098-1861</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1zsFKAzEQgOEcFFurryD7AoEk0ySToyxVCxVBei_JzoRWtpuwuz3Up_egnv7bx38jlloFlBqdXoj7afpSCoxFvBMLE8B6o81SQBsnbj65lnFuSm7eeR7LcKL4XXqW24EuHVOzGTqux9iXGufj9UHc5thP_PjXldi_bPbtm9x9vG7b552sAWZJLiVSSTFFxUl7sBjIg_HoYqKMMYd16BiSwQzZBnaO1hhMZ9kY5y2sxNMvWy_pzHSo4-kcx-vhfx5-AGAbP7M</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Clements, Adam</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201712</creationdate><title>Case Report of Metronidazole-Induced Encephalopathy</title><author>Clements, Adam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p93t-d6bbd0b0eda0eb173589d732786abdf8af949ce3b28f3f59e66d4892c5e226753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - adverse effects</topic><topic>Brain Diseases - chemically induced</topic><topic>Brain Diseases - diagnostic imaging</topic><topic>Clostridium Infections - drug therapy</topic><topic>Colitis - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Metronidazole - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clements, Adam</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Wisconsin medical journal (Madison, Wis.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clements, Adam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case Report of Metronidazole-Induced Encephalopathy</atitle><jtitle>Wisconsin medical journal (Madison, Wis.)</jtitle><addtitle>WMJ</addtitle><date>2017-12</date><risdate>2017</risdate><volume>116</volume><issue>5</issue><spage>221</spage><pages>221-</pages><issn>1098-1861</issn><abstract>This report describes the case of an 83-year-old woman who was admitted to a hospitalist service with weakness and falls. She was transferred from an outside facility where she was treated with 3 courses of metronidazole for diagnosed Clostridium difficile colitis and presumed reoccurrences. Magnetic resonance imaging (MRI) demonstrated T2 enhancement of the dorsal pons and dentate nuclei consistent with metronidazole-induced encephalopathy. Her metronidazole was stopped and her symptoms resolved. This condition is rare, poorly understood, and causes reversible changes in the brain that are detectable through T2-weighted MRI. It will need ongoing study with current widespread use of metronidazole.</abstract><cop>United States</cop><pmid>29357212</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1098-1861 |
ispartof | Wisconsin medical journal (Madison, Wis.), 2017-12, Vol.116 (5), p.221 |
issn | 1098-1861 |
language | eng |
recordid | cdi_pubmed_primary_29357212 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Aged, 80 and over Anti-Infective Agents - adverse effects Brain Diseases - chemically induced Brain Diseases - diagnostic imaging Clostridium Infections - drug therapy Colitis - drug therapy Female Humans Magnetic Resonance Imaging Metronidazole - adverse effects |
title | Case Report of Metronidazole-Induced Encephalopathy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T20%3A13%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20Report%20of%20Metronidazole-Induced%20Encephalopathy&rft.jtitle=Wisconsin%20medical%20journal%20(Madison,%20Wis.)&rft.au=Clements,%20Adam&rft.date=2017-12&rft.volume=116&rft.issue=5&rft.spage=221&rft.pages=221-&rft.issn=1098-1861&rft_id=info:doi/&rft_dat=%3Cpubmed%3E29357212%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29357212&rfr_iscdi=true |